Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Respiratory Syncytial Virus Immunology
Research conducted at State University of New York has provided new information about respiratory syncytial virus immunology
May 14th, 2008
Data detailed in 'The immune response to respiratory syncytial virus infection: friend or foe' have been presented. According to recent research published in the journal Clinical Reviews In Allergy and Immunology, "The immune response to respiratory syncytial virus (RSV) infection has fascinated and frustrated investigators for decades. After adverse responses to early attempts at vaccination, it became popularly held that disease following infection was related to overly aggressive immune responses." "However, recent data illustrate that severe forms of disease are related to inadequate, rather than hyperresponsive, adaptive immune reactions. Thus, recovery from...
Source: Vaccine Weekly (2008-05-14)
|
